98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084359 | PMC |
http://dx.doi.org/10.5603/CJ.2019.0076 | DOI Listing |
Catheter Cardiovasc Interv
September 2025
Cardiology Department, Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain.
We present the first case of a double atrial septal defect (ASD) successfully reshaped using transcatheter electrosurgery to unify both defects into a single orifice, enabling closure with a single device. This technique appears feasible and may simplify the management of complex double ASDs in some cases.
View Article and Find Full Text PDFREC Interv Cardiol
March 2025
Instituto de Investigación del Hospital Universitario La Paz (idiPAZ), Madrid, España Instituto de Investigación del Hospital Universitario La Paz (idiPAZ) Instituto de Investigación del Hospital Universitario La Paz (idiPAZ) Madrid España.
Rev Esp Cardiol (Engl Ed)
September 2025
Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, España; Servicio de Cardiología, Hospital Clínico de Santiago de Compostela, Santiago de Compostela, España.
Introduction And Objectives: This report presents the 2024 activity data from the Interventional Cardiology Association of the Spanish Society of Cardiology (ACI-SEC).
Methods: All interventional cardiology laboratories in Spain were invited to complete an online survey. Data analysis was conducted by an external company and then reviewed and presented by the ACI-SEC board.
JACC Case Rep
September 2025
Center for Structural Heart Disease, Henry Ford Health System, Detroit, Michigan, USA. Electronic address:
Case Summary: We present a case of a 31-year-old man with a history of aortic valve endocarditis and surgical aortic intervention. Computed tomography revealed a complex serpiginous fistula with 2 openings between the left ventricular outflow tract and the left atrium. Using 3-dimensional printing simulation for device fit testing and planning, the "mother-in-daughter" system, multimodality guidance with computed tomography angiography C-arm prediction, and 3-dimensional transesophageal echocardiogram guidance successfully guided an 18-mm Cribriform Amplatzer device deployed via a retrograde approach.
View Article and Find Full Text PDFWorld J Methodol
December 2025
Department of Cardiology, University of Miami-Miller School of Medicine, Miami, FL 33136, United States.
Background: The Food and Drug Administration has approved percutaneous atrial septal defect (ASD) and patent foramen ovale (PFO) closure devices for hemodynamically significant interatrial shunts, paradoxical emboli including stroke, and decompression sickness. We aimed to study the trends in utilization and reimbursements of transcatheter ASD/PFO closure devices.
Aim: To analyze trends in utilization and Medicare reimbursements for transcatheter ASD/PFO closure procedures from 2013 to 2022.